Sign up | Login with →

News

exclusive

A Virtual Brain – The Benefits of Brain Modelling

May 25, 2016 by Viatcheslav Wlassoff

Simulations have proved to be a useful tool in many fields of science. Pharmaceutical companies are now using molecular modelling to understand the behavior of medicines and guide the design of new drugs. When building aircraft, aeronautical engineers rely on modelling so heavily that no airplane prototype goes into real flight without...[read more]

Diagnostic Reading: “Must Read” Articles on HIT and Radiology

May 17, 2016 by Erica Carnevale

HealthIT is improving care; expectations for radiology reports are increasingThis week’s articles include: executives support for health IT technology; need for improvements in radiology reporting; a Gallup survey shows healthcare costs are greatest concern for many Americans; two-thirds of healthcare organizations believe personalized...[read more]

exclusive

Rising 21st Century Trends in Healthcare

May 17, 2016 by Ryan Kh

The future for medicine is far brighter than its past, as it should be. The 21st century is certain to usher in revolutions in the world of healthcare, as the century before it proved to do as well. For us in the meantime, it can seem like the so-called progress never materializes, but even in 2016, the seemingly future of medicine is already present.[read more]

exclusive

Five Fields In Healthcare That Are Quickly Growing

May 17, 2016 by Anita Ginsburg

The healthcare industry can be extremely lucrative, but it is tough for many students and professionals to decide which fields are growing and in need of new talent. Here is a list of five healthcare fields that are not only growing today, but also estimated to need thousands of new employees in the coming years.[read more]

exclusive

Moles: Simple Skin Issue or Something More?

May 12, 2016 by Viatcheslav Wlassoff

This article presents a selection of research papers on the subject of neuroscience and neurology published in April. As usual, many new interesting findings were made public this month, and the selection presented here reflects mostly my personal opinion of their importance.[read more]

Should the FDA Approve Experimental Treatment for Severe Diseases?

May 9, 2016 by Michael Kirsch

In the news recently is a conflict between families of kids with Duchenne muscular dystrophy and the Food and Drug Administration (FDA). A very small study of an experimental drug called eteplirsen suggested some benefit. But not enough is known.[read more]

Patient Centricity – It’s Time for a New Focus

May 9, 2016 by Danyell Jones

Patient Centricity is not just the newest healthcare buzzword, it is an emerging concept that is here to stay! Healthcare is currently making rapid shifts, and one of the most fundamental of these shifts is the shift to what industry professionals are terming “patient centricity.”[read more]

California Supreme Court Rebuts Court Ruling On UR Physician Liability

April 29, 2016 by Josh Nelson

Medical reviewers and workers’ compensation providers can breathe a sigh of relief – at least for now. Last week the California Supreme Court ruled to officially depublicize a lower court’s previous ruling on the utilization review (UR) and workers’ compensation industries that would have set a precedent by holding UR physicians responsible for the care of patients whose cases the physicians review.[read more]

Good riddance: United finally gives up on ACA marketplaces

April 28, 2016 by David E Williams

United Healthcare announced that it’s exiting most of the Obamacare insurance marketplaces (aka exchanges) next year. Sound like a familiar story? In fact all the recent news coverage is just a rehash of last November’s announcement that United was probably going to exit.[read more]

Five “Must Read” Articles on Radiology and Health IT

April 28, 2016 by Erica Carnevale

Radiology consults, healthIT data breaches and telemedicine make the news. This week’s articles include a study that shows how delivering personalized care to patients could increase revenues;[read more]

Tackling the Side Effects of Parkinson’s Treatment

April 17, 2016 by Viatcheslav Wlassoff

Parkinson’s disease is a slowly developing progressive disorder which is estimated to be the second most common neurodegenerative disease. At present, the disease affects 5 million people and the numbers are projected to reach 9 million by the year 2030.[read more]

exclusive

How That New Drug Goes From Idea to Market

April 16, 2016 by Ryan Kh

The development and approval of new drugs is mandated by FDA's CDER (Center for Drug Evaluation and Research) center, the apex government body governing this segment. So how is a drug conceptualized and then developed, marketed, and then transported to various parts of the country for storage, management, and transportation of drugs?[read more]